Criterion and construct validity of the Beck Depression Inventory (BDI-II) to measure depression in patients with cancer: The contribution of somatic items

Detalhes bibliográficos
Autor(a) principal: Almeida, Sílvia
Data de Publicação: 2022
Outros Autores: Camacho, Marta, Barahona-Corrêa, J. Bernardo, Oliveira, José, Lemos, Raquel, Da Silva Rodrigues, Daniel, da Silva, Joaquim Alves, Baptista, Telmo Mourinho, Grácio, Jaime, Oliveira-Maia, Albino J.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.12/8893
Resumo: Background/Objective: Screening for depression in patients with cancer can be difficult due to overlap between symptoms of depression and cancer. We assessed validity of the Beck Depression Inventory (BDI-II) in this population. Method: Data was obtained in an outpatient neuropsychiatry unit treating patients with and without cancer. Psychometric properties of the BDI-II Portuguese version were assessed separately in 202 patients with cancer, and 376 outpatients with mental health complaints but without cancer. Results: Confirmatory factor analysis suggested a three-factor structure model (cognitive, affective and somatic) provided best fit to data in both samples. Criterion validity was good for detecting depression in oncological patients, with an area under the ROC curve (AUC) of 0.85 (95% confidence interval [CI], 0.760.91). A cut-off score of 14 had sensitivity of 87% and specificity of 73%. Excluding somatic items did not significantly change the ROC curve for BDI-II (difference AUCs = 0.002, p=0.9). A good criterion validity for BDI-II was also obtained in the non-oncological population (AUC = 0.87; 95% CI 0.810.91), with a cut-off of 18 (sensitivity=84%; specificity=73%). Conclusions: The BDI-II demonstrated good psychometric properties in patients with cancer, comparable to a population without cancer. Exclusion of somatic items did not affect screening accuracy
id RCAP_0482597f31729d3d8cda93bb94a2abf6
oai_identifier_str oai:repositorio.ispa.pt:10400.12/8893
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Criterion and construct validity of the Beck Depression Inventory (BDI-II) to measure depression in patients with cancer: The contribution of somatic itemsDepressionCancerBDI-IIPsychometryAssessmentBackground/Objective: Screening for depression in patients with cancer can be difficult due to overlap between symptoms of depression and cancer. We assessed validity of the Beck Depression Inventory (BDI-II) in this population. Method: Data was obtained in an outpatient neuropsychiatry unit treating patients with and without cancer. Psychometric properties of the BDI-II Portuguese version were assessed separately in 202 patients with cancer, and 376 outpatients with mental health complaints but without cancer. Results: Confirmatory factor analysis suggested a three-factor structure model (cognitive, affective and somatic) provided best fit to data in both samples. Criterion validity was good for detecting depression in oncological patients, with an area under the ROC curve (AUC) of 0.85 (95% confidence interval [CI], 0.760.91). A cut-off score of 14 had sensitivity of 87% and specificity of 73%. Excluding somatic items did not significantly change the ROC curve for BDI-II (difference AUCs = 0.002, p=0.9). A good criterion validity for BDI-II was also obtained in the non-oncological population (AUC = 0.87; 95% CI 0.810.91), with a cut-off of 18 (sensitivity=84%; specificity=73%). Conclusions: The BDI-II demonstrated good psychometric properties in patients with cancer, comparable to a population without cancer. Exclusion of somatic items did not affect screening accuracyFundação para a Ciência e Tecnologia - FCTElsevier DoymaRepositório do ISPAAlmeida, SílviaCamacho, MartaBarahona-Corrêa, J. BernardoOliveira, JoséLemos, RaquelDa Silva Rodrigues, Danielda Silva, Joaquim AlvesBaptista, Telmo MourinhoGrácio, JaimeOliveira-Maia, Albino J.2022-12-29T16:21:10Z20232023-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.12/8893engAlmeida, S., Camacho, M., Barahona-Corrêa, J. B., Oliveira, J., Lemos, R., da Silva, D. R., da Silva, J. A., Baptista, T. M., Grácio, J., & Oliveira-Maia, A. J. (2023). Criterion and construct validity of the Beck Depression Inventory (BDI-II) to measure depression in patients with cancer: The contribution of somatic items. International Journal of Clinical and Health Psychology, 23(2). https://doi.org/10.1016/j.ijchp.2022.1003501697260010.1016/j.ijchp.2022.100350info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-01-01T02:15:51Zoai:repositorio.ispa.pt:10400.12/8893Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:29:14.040906Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Criterion and construct validity of the Beck Depression Inventory (BDI-II) to measure depression in patients with cancer: The contribution of somatic items
title Criterion and construct validity of the Beck Depression Inventory (BDI-II) to measure depression in patients with cancer: The contribution of somatic items
spellingShingle Criterion and construct validity of the Beck Depression Inventory (BDI-II) to measure depression in patients with cancer: The contribution of somatic items
Almeida, Sílvia
Depression
Cancer
BDI-II
Psychometry
Assessment
title_short Criterion and construct validity of the Beck Depression Inventory (BDI-II) to measure depression in patients with cancer: The contribution of somatic items
title_full Criterion and construct validity of the Beck Depression Inventory (BDI-II) to measure depression in patients with cancer: The contribution of somatic items
title_fullStr Criterion and construct validity of the Beck Depression Inventory (BDI-II) to measure depression in patients with cancer: The contribution of somatic items
title_full_unstemmed Criterion and construct validity of the Beck Depression Inventory (BDI-II) to measure depression in patients with cancer: The contribution of somatic items
title_sort Criterion and construct validity of the Beck Depression Inventory (BDI-II) to measure depression in patients with cancer: The contribution of somatic items
author Almeida, Sílvia
author_facet Almeida, Sílvia
Camacho, Marta
Barahona-Corrêa, J. Bernardo
Oliveira, José
Lemos, Raquel
Da Silva Rodrigues, Daniel
da Silva, Joaquim Alves
Baptista, Telmo Mourinho
Grácio, Jaime
Oliveira-Maia, Albino J.
author_role author
author2 Camacho, Marta
Barahona-Corrêa, J. Bernardo
Oliveira, José
Lemos, Raquel
Da Silva Rodrigues, Daniel
da Silva, Joaquim Alves
Baptista, Telmo Mourinho
Grácio, Jaime
Oliveira-Maia, Albino J.
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do ISPA
dc.contributor.author.fl_str_mv Almeida, Sílvia
Camacho, Marta
Barahona-Corrêa, J. Bernardo
Oliveira, José
Lemos, Raquel
Da Silva Rodrigues, Daniel
da Silva, Joaquim Alves
Baptista, Telmo Mourinho
Grácio, Jaime
Oliveira-Maia, Albino J.
dc.subject.por.fl_str_mv Depression
Cancer
BDI-II
Psychometry
Assessment
topic Depression
Cancer
BDI-II
Psychometry
Assessment
description Background/Objective: Screening for depression in patients with cancer can be difficult due to overlap between symptoms of depression and cancer. We assessed validity of the Beck Depression Inventory (BDI-II) in this population. Method: Data was obtained in an outpatient neuropsychiatry unit treating patients with and without cancer. Psychometric properties of the BDI-II Portuguese version were assessed separately in 202 patients with cancer, and 376 outpatients with mental health complaints but without cancer. Results: Confirmatory factor analysis suggested a three-factor structure model (cognitive, affective and somatic) provided best fit to data in both samples. Criterion validity was good for detecting depression in oncological patients, with an area under the ROC curve (AUC) of 0.85 (95% confidence interval [CI], 0.760.91). A cut-off score of 14 had sensitivity of 87% and specificity of 73%. Excluding somatic items did not significantly change the ROC curve for BDI-II (difference AUCs = 0.002, p=0.9). A good criterion validity for BDI-II was also obtained in the non-oncological population (AUC = 0.87; 95% CI 0.810.91), with a cut-off of 18 (sensitivity=84%; specificity=73%). Conclusions: The BDI-II demonstrated good psychometric properties in patients with cancer, comparable to a population without cancer. Exclusion of somatic items did not affect screening accuracy
publishDate 2022
dc.date.none.fl_str_mv 2022-12-29T16:21:10Z
2023
2023-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.12/8893
url http://hdl.handle.net/10400.12/8893
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Almeida, S., Camacho, M., Barahona-Corrêa, J. B., Oliveira, J., Lemos, R., da Silva, D. R., da Silva, J. A., Baptista, T. M., Grácio, J., & Oliveira-Maia, A. J. (2023). Criterion and construct validity of the Beck Depression Inventory (BDI-II) to measure depression in patients with cancer: The contribution of somatic items. International Journal of Clinical and Health Psychology, 23(2). https://doi.org/10.1016/j.ijchp.2022.100350
16972600
10.1016/j.ijchp.2022.100350
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier Doyma
publisher.none.fl_str_mv Elsevier Doyma
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130749822042112

Registros relacionados